Industry: Pharma & Healthcare
Published Date: 2024-01-24
Pages: 101 Pages
Report ld: 2333632
Request Sample
Customized Report
The metabotropic glutamate receptors are a type of glutamate receptor that are active through an indirect metabotropic process.
The global market for Metabotropic Glutamate Receptor (MRG) was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Metabotropic Glutamate Receptor (MRG) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Metabotropic Glutamate Receptor (MRG) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Metabotropic Glutamate Receptor (MRG) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Metabotropic Glutamate Receptor (MRG) include Addex Therapeutics, Domain Therapeutics, Medgenics, Prexton Therapeutics and Taisho Pharmaceutical Holding, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
MARKET SEGMENTATION
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Metabotropic Glutamate Receptor (MRG), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Metabotropic Glutamate Receptor (MRG) by region & country, by Type, and by Application.
The Metabotropic Glutamate Receptor (MRG) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metabotropic Glutamate Receptor (MRG).
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Metabotropic Glutamate Receptor (MRG) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Metabotropic Glutamate Receptor (MRG) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Metabotropic Glutamate Receptor (MRG) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Metabotropic Glutamate Receptor (MRG) Product Introduction
1.2 Global Metabotropic Glutamate Receptor (MRG) Market Size Forecast
1.2.1 Global Metabotropic Glutamate Receptor (MRG) Sales Value (2019-2030)
1.2.2 Global Metabotropic Glutamate Receptor (MRG) Sales Volume (2019-2030)
1.2.3 Global Metabotropic Glutamate Receptor (MRG) Sales Price (2019-2030)
1.3 Metabotropic Glutamate Receptor (MRG) Market Trends & Drivers
1.3.1 Metabotropic Glutamate Receptor (MRG) Industry Trends
1.3.2 Metabotropic Glutamate Receptor (MRG) Market Drivers & Opportunity
1.3.3 Metabotropic Glutamate Receptor (MRG) Market Challenges
1.3.4 Metabotropic Glutamate Receptor (MRG) Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Metabotropic Glutamate Receptor (MRG) Players Revenue Ranking (2023)
2.2 Global Metabotropic Glutamate Receptor (MRG) Revenue by Company (2019-2024)
2.3 Global Metabotropic Glutamate Receptor (MRG) Players Sales Volume Ranking (2023)
2.4 Global Metabotropic Glutamate Receptor (MRG) Sales Volume by Company Players (2019-2024)
2.5 Global Metabotropic Glutamate Receptor (MRG) Average Price by Company (2019-2024)
2.6 Key Manufacturers Metabotropic Glutamate Receptor (MRG) Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Metabotropic Glutamate Receptor (MRG) Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Metabotropic Glutamate Receptor (MRG)
2.9 Metabotropic Glutamate Receptor (MRG) Market Competitive Analysis
2.9.1 Metabotropic Glutamate Receptor (MRG) Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Metabotropic Glutamate Receptor (MRG) Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metabotropic Glutamate Receptor (MRG) as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 mGluR2
3.1.2 mGluR4
3.1.3 mGluR5
3.2 Global Metabotropic Glutamate Receptor (MRG) Sales Value by Type
3.2.1 Global Metabotropic Glutamate Receptor (MRG) Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Metabotropic Glutamate Receptor (MRG) Sales Value, by Type (2019-2030)
3.2.3 Global Metabotropic Glutamate Receptor (MRG) Sales Value, by Type (%) (2019-2030)
3.3 Global Metabotropic Glutamate Receptor (MRG) Sales Volume by Type
3.3.1 Global Metabotropic Glutamate Receptor (MRG) Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Metabotropic Glutamate Receptor (MRG) Sales Volume, by Type (2019-2030)
3.3.3 Global Metabotropic Glutamate Receptor (MRG) Sales Volume, by Type (%) (2019-2030)
3.4 Global Metabotropic Glutamate Receptor (MRG) Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Meningitis
4.1.2 Septicemia
4.1.3 Others
4.2 Global Metabotropic Glutamate Receptor (MRG) Sales Value by Application
4.2.1 Global Metabotropic Glutamate Receptor (MRG) Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Metabotropic Glutamate Receptor (MRG) Sales Value, by Application (2019-2030)
4.2.3 Global Metabotropic Glutamate Receptor (MRG) Sales Value, by Application (%) (2019-2030)
4.3 Global Metabotropic Glutamate Receptor (MRG) Sales Volume by Application
4.3.1 Global Metabotropic Glutamate Receptor (MRG) Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Metabotropic Glutamate Receptor (MRG) Sales Volume, by Application (2019-2030)
4.3.3 Global Metabotropic Glutamate Receptor (MRG) Sales Volume, by Application (%) (2019-2030)
4.4 Global Metabotropic Glutamate Receptor (MRG) Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Metabotropic Glutamate Receptor (MRG) Sales Value by Region
5.1.1 Global Metabotropic Glutamate Receptor (MRG) Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Metabotropic Glutamate Receptor (MRG) Sales Value by Region (2019-2024)
5.1.3 Global Metabotropic Glutamate Receptor (MRG) Sales Value by Region (2025-2030)
5.1.4 Global Metabotropic Glutamate Receptor (MRG) Sales Value by Region (%), (2019-2030)
5.2 Global Metabotropic Glutamate Receptor (MRG) Sales Volume by Region
5.2.1 Global Metabotropic Glutamate Receptor (MRG) Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Metabotropic Glutamate Receptor (MRG) Sales Volume by Region (2019-2024)
5.2.3 Global Metabotropic Glutamate Receptor (MRG) Sales Volume by Region (2025-2030)
5.2.4 Global Metabotropic Glutamate Receptor (MRG) Sales Volume by Region (%), (2019-2030)
5.3 Global Metabotropic Glutamate Receptor (MRG) Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Metabotropic Glutamate Receptor (MRG) Sales Value, 2019-2030
5.4.2 North America Metabotropic Glutamate Receptor (MRG) Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Metabotropic Glutamate Receptor (MRG) Sales Value, 2019-2030
5.5.2 Europe Metabotropic Glutamate Receptor (MRG) Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Metabotropic Glutamate Receptor (MRG) Sales Value, 2019-2030
5.6.2 Asia Pacific Metabotropic Glutamate Receptor (MRG) Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Metabotropic Glutamate Receptor (MRG) Sales Value, 2019-2030
5.7.2 South America Metabotropic Glutamate Receptor (MRG) Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Metabotropic Glutamate Receptor (MRG) Sales Value, 2019-2030
5.8.2 Middle East & Africa Metabotropic Glutamate Receptor (MRG) Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Metabotropic Glutamate Receptor (MRG) Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Metabotropic Glutamate Receptor (MRG) Sales Value
6.2.1 Key Countries/Regions Metabotropic Glutamate Receptor (MRG) Sales Value, 2019-2030
6.2.2 Key Countries/Regions Metabotropic Glutamate Receptor (MRG) Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Metabotropic Glutamate Receptor (MRG) Sales Value, 2019-2030
6.3.2 United States Metabotropic Glutamate Receptor (MRG) Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Metabotropic Glutamate Receptor (MRG) Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Metabotropic Glutamate Receptor (MRG) Sales Value, 2019-2030
6.4.2 Europe Metabotropic Glutamate Receptor (MRG) Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Metabotropic Glutamate Receptor (MRG) Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Metabotropic Glutamate Receptor (MRG) Sales Value, 2019-2030
6.5.2 China Metabotropic Glutamate Receptor (MRG) Sales Value by Type (%), 2023 VS 2030
6.5.3 China Metabotropic Glutamate Receptor (MRG) Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Metabotropic Glutamate Receptor (MRG) Sales Value, 2019-2030
6.6.2 Japan Metabotropic Glutamate Receptor (MRG) Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Metabotropic Glutamate Receptor (MRG) Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Metabotropic Glutamate Receptor (MRG) Sales Value, 2019-2030
6.7.2 South Korea Metabotropic Glutamate Receptor (MRG) Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Metabotropic Glutamate Receptor (MRG) Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Metabotropic Glutamate Receptor (MRG) Sales Value, 2019-2030
6.8.2 Southeast Asia Metabotropic Glutamate Receptor (MRG) Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Metabotropic Glutamate Receptor (MRG) Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Metabotropic Glutamate Receptor (MRG) Sales Value, 2019-2030
6.9.2 India Metabotropic Glutamate Receptor (MRG) Sales Value by Type (%), 2023 VS 2030
6.9.3 India Metabotropic Glutamate Receptor (MRG) Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Addex Therapeutics
7.1.1 Addex Therapeutics Company Information
7.1.2 Addex Therapeutics Introduction and Business Overview
7.1.3 Addex Therapeutics Metabotropic Glutamate Receptor (MRG) Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Addex Therapeutics Metabotropic Glutamate Receptor (MRG) Product Offerings
7.1.5 Addex Therapeutics Recent Development
7.2 Domain Therapeutics
7.2.1 Domain Therapeutics Company Information
7.2.2 Domain Therapeutics Introduction and Business Overview
7.2.3 Domain Therapeutics Metabotropic Glutamate Receptor (MRG) Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Domain Therapeutics Metabotropic Glutamate Receptor (MRG) Product Offerings
7.2.5 Domain Therapeutics Recent Development
7.3 Medgenics
7.3.1 Medgenics Company Information
7.3.2 Medgenics Introduction and Business Overview
7.3.3 Medgenics Metabotropic Glutamate Receptor (MRG) Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Medgenics Metabotropic Glutamate Receptor (MRG) Product Offerings
7.3.5 Medgenics Recent Development
7.4 Prexton Therapeutics
7.4.1 Prexton Therapeutics Company Information
7.4.2 Prexton Therapeutics Introduction and Business Overview
7.4.3 Prexton Therapeutics Metabotropic Glutamate Receptor (MRG) Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Prexton Therapeutics Metabotropic Glutamate Receptor (MRG) Product Offerings
7.4.5 Prexton Therapeutics Recent Development
7.5 Taisho Pharmaceutical Holding
7.5.1 Taisho Pharmaceutical Holding Company Information
7.5.2 Taisho Pharmaceutical Holding Introduction and Business Overview
7.5.3 Taisho Pharmaceutical Holding Metabotropic Glutamate Receptor (MRG) Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Taisho Pharmaceutical Holding Metabotropic Glutamate Receptor (MRG) Product Offerings
7.5.5 Taisho Pharmaceutical Holding Recent Development
8 Industry Chain Analysis
8.1 Metabotropic Glutamate Receptor (MRG) Industrial Chain
8.2 Metabotropic Glutamate Receptor (MRG) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Metabotropic Glutamate Receptor (MRG) Sales Model
8.5.2 Sales Channel
8.5.3 Metabotropic Glutamate Receptor (MRG) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Metabotropic Glutamate Receptor (MRG) was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-15
Pages: 123
USD 3950.00
(Single User License)
The global Metabotropic Glutamate Receptor (MRG) market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-28
Pages: 90
USD 2900.00
(Single User License)
The global Metabotropic Glutamate Receptor (MRG) market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 69
USD 4250.00
(Single User License)
The global market for Metabotropic Glutamate Receptor (MRG) was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-25
Pages: 83
USD 3950.00
(Single User License)
The global market for Metabotropic Glutamate Receptor (MRG) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-25
Pages: 68
USD 2900.00
(Single User License)
The metabotropic glutamate receptors are a type of glutamate receptor that are active through an indirect metabotropic process.
Published Date: 2024-04-26
Pages: 85
USD 4900.00
(Single User License)
The metabotropic glutamate receptors are a type of glutamate receptor that are active through an indirect metabotropic process.
Published Date: 2024-01-31
Pages: 81
USD 2900.00
(Single User License)
The global market for Metabotropic Glutamate Receptor (MRG) was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-15
Pages: 123
The global Metabotropic Glutamate Receptor (MRG) market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-28
Pages: 90
The global Metabotropic Glutamate Receptor (MRG) market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 69
The global market for Metabotropic Glutamate Receptor (MRG) was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-25
Pages: 83
The global market for Metabotropic Glutamate Receptor (MRG) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-25
Pages: 68
The metabotropic glutamate receptors are a type of glutamate receptor that are active through an indirect metabotropic process.
Published: 2024-04-26
Pages: 85
The metabotropic glutamate receptors are a type of glutamate receptor that are active through an indirect metabotropic process.
Published: 2024-01-31
Pages: 81
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now